Skip to main content

Table 4 Diagnostic performances of CEUS and CECT LI-RADS for HCC and non-HCC malignancies

From: Differences between CEUS LI-RADS and CECT LI-RADS in the diagnosis of focal liver lesions in patients at risk for HCC

Variables

HCC

Non-HCC malignancies

CEUS LR-5

CECT LR-5

p

CEUS LR-M

CECT LR-M

p

TP

113

168

 

30

26

 

TN

51

47

 

145

232

 

FP

6

10

 

98

11

 

FN

107

52

 

4

8

 

Sens. (%)

51.4 (44.6, 58.1)

76.4 (70.2, 81.8)

< 0.001

88.2 (72.6, 96.7)

76.5 (58.8, 89.3)

0.344

Spec. (%)

89.5 (78.5, 96.0)

82.5 (70.1, 91.3)

0.424

59.7 (53.2, 65.9)

95.5 (92.1, 97.7)

< 0.001

PPV (%)

95.0 (89.7, 97.6)

94.4 (90.5, 96.7)

0.830

23.4 (20.1, 27.1)

70.3 (56.3, 81.3)

< 0.001

NPV (%)

32.3 (28.8, 35.9)

47.5 (40.9, 54.1)

0.015

97.3 (93.5, 98.9)

96.7 (94.1, 98.2)

0.719

  1. Note—Values in parentheses are 95% confidence intervals. TP = true positive; TN = true negative; FP = false positive, FN = false negative; Sens. = Sensitivity; Spec. = specificity
Back to article page

BMC Medical Imaging

ISSN: 1471-2342

Contact us